Skip to content
★ Sign in to follow
UC

US-China Biomedical Technology, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by China Israel Biotechnology Co. Ltd, was filed 05 Jul 2019.

US-China Biomedical Technology, Inc.: what insiders have been doing

This page follows insider dealings at US-China Biomedical Technology, Inc. as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for US-China Biomedical Technology, Inc. The previous disclosure was published on 5 July 2019.

Looking back to 2015, when coverage begins, insiders filed 13 purchases and 1 sale.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€151,937
13 ops. · all time
Sell Volume
€338,790
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2017

FY ended February 2017 · cache

Income statement
Net income-633.7k
Last declaration on 5 July 2019
Declarations16 total
  • ▲
    Related company / holdingExecutives
    0SEC
    4,290,000 sharesCommon StockSEC:0001683168-19-002123:0
    Canonical exit: 27 Aug 2019 (T+90)
  • ▲
    CEO, CFO, Secy., Treas.Executives
    0SEC
    4,290,000 sharesCommon StockSEC:0001683168-19-002124:0
    Canonical exit: 27 Aug 2019 (T+90)
  • ●
    CEO, CFO, PresidentExecutives
    0SEC
    200,000 shares0Common StockSEC:0001683168-17-001968:1
  • ●
    Senior Vice PresidentExecutives
    0SEC
    200,000 shares0Common StockSEC:0001683168-17-001993:0
  • ▼
    Related company / holdingExecutives
    396,000 USD13SEC
    12,000,000 shares@ US$0.033100.0% of flowCommon StockSEC:0001683168-17-001927:0
  • ▲
    CEO, CFO, PresidentExecutives
    115,500 USD30SEC
    3,500,000 shares@ US$0.033100.0% of flowCommon StockSEC:0001683168-17-001926:0
    Canonical exit: 26 Oct 2017 (T+90)
  • ▲
    SecretaryExecutives
    1,480 USD0SEC
    1,000 shares@ US$1.48Common StockSEC:0001019687-15-003240:0
    Canonical exit: 30 Aug 2015 (T+90)
  • ▲
    SecretaryExecutives
    988 USD0SEC
    520 shares@ US$1.90Common StockSEC:0001019687-15-003240:1
    Canonical exit: 21 Sept 2015 (T+90)
  • ▲
    SecretaryExecutives
    415 USD0SEC
    100 shares@ US$4.15Common StockSEC:0001019687-15-003240:2
    Canonical exit: 7 Oct 2015 (T+90)
  • ▲
    SecretaryExecutives
    20,580 USD0SEC
    4,900 shares@ US$4.20Common StockSEC:0001019687-15-003240:3
    Canonical exit: 8 Oct 2015 (T+90)
  • ▲
    SecretaryExecutives
    7,343 USD0SEC
    1,650 shares@ US$4.45Common StockSEC:0001019687-15-003240:4
    Canonical exit: 11 Oct 2015 (T+90)
  • ▲
    SecretaryExecutives
    14,565 USD0SEC
    3,273 shares@ US$4.45Common StockSEC:0001019687-15-003240:5
    Canonical exit: 12 Oct 2015 (T+90)
  • ▲
    SecretaryExecutives
    270 USD0SEC
    77 shares@ US$3.50Common StockSEC:0001019687-15-003240:6
    Canonical exit: 13 Oct 2015 (T+90)
  • ▲
    SecretaryExecutives
    1,656 USD0SEC
    230 shares@ US$7.20Common StockSEC:0001019687-15-003240:7
    Canonical exit: 1 Nov 2015 (T+90)
  • ▲
    SecretaryExecutives
    9,640 USD0SEC
    1,205 shares@ US$8.00Common StockSEC:0001019687-15-003240:8
    Canonical exit: 1 Nov 2015 (T+90)
  • ▲
    SecretaryExecutives
    1,575 USD0SEC
    250 shares@ US$6.30Common StockSEC:0001019687-15-003240:9
    Canonical exit: 1 Nov 2015 (T+90)

16 of 16 declarations

About US-China Biomedical Technology, Inc.

US-China Biomedical Technology, Inc. is a company focused on developing biomedical technologies between the United States and China. It concentrates on innovation in the healthcare and biotechnology sectors.